Document Detail


Expression of eicosanoid biosynthetic and catabolic enzymes in peritoneal endometriosis.
MedLine Citation:
PMID:  20023295     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Increased peritoneal eicosanoid concentrations have been reported in endometriosis patients and might be important in disease-associated pain and inflammation. Here, we evaluated the expression of key biosynthetic and catabolic enzymes involved in this abnormal eicosanoid production in peritoneal macrophages and endometriotic lesions. METHODS: Peritoneal macrophages, endometriotic lesions and matched eutopic endometrium were collected from endometriosis patients (n = 40). Peritoneal macrophages and eutopic endometrium samples were also collected from disease-free women (n = 25). Expression of type IIA secretory phospholipase A(2) (sPLA(2)-IIA), cyclooxygenase-2 (COX-2), microsomal prostaglandin E synthase-1 (mPGES-1), 15-hydroxyprostaglandin dehydrogenase (15-PGDH) and 5-lipoxygenase (5-LO) was quantified by real-time PCR, and these five key enzymes were localized by immunohistochemistry. RESULTS: sPLA(2)-IIA, COX-2 and mPGES-1 mRNA was significantly increased in peritoneal macrophages of endometriosis patients compared with controls (P = 0.006, P = 0.016 and P = 0.025, respectively). In endometriosis patients, sPLA(2)-IIA, mPGES-1 and 15-PGDH mRNA was significantly enhanced in peritoneal lesions compared with matched eutopic endometrium (P < 0.001, P < 0.001 and P = 0.005, respectively). In eutopic endometrium, a significant decrease in 15-PGDH mRNA was found in the endometriosis group compared with controls (P = 0.023). Finally, sPLA(2)-IIA, COX-2, mPGES-1 and 15-PGDH immunostaining was found mainly in endometrial glands, whereas 5-LO was distributed throughout the glands and stroma. CONCLUSIONS: Our study highlights an imbalance between eicosanoid biosynthesis and degradation in endometriosis patients. Both peritoneal macrophages and endometriotic lesions may be involved. Research into new molecules inhibiting biosynthetic enzymes (such as sPLA(2)-IIA and mPGES-1) and/or activating catabolic enzymes (such as 15-PGDH) may prove to be a major field of investigation in the development of targeted medical therapies.
Authors:
J-C Lousse; S Defr?re; S Colette; A Van Langendonckt; J Donnez
Related Documents :
169915 - Organization of phospholipids in human red cell membranes as detected by the action of ...
19000915 - Bthmp: a new weakly hemorrhagic metalloproteinase from bothrops moojeni snake venom.
12482475 - High-performance liquid chromatographic assay with ultraviolet spectrometric detection ...
275865 - Low concentrations of indomethacin inhibit phospholipase a2 of rabbit polymorphonuclear...
2477995 - 1,2-dioxetanes: novel chemiluminescent enzyme substrates. applications to immunoassays.
2857095 - The sulphatase of ox liver. xxv. sulphatase a as a hysteretic enzyme.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-12-19
Journal Detail:
Title:  Human reproduction (Oxford, England)     Volume:  25     ISSN:  1460-2350     ISO Abbreviation:  Hum. Reprod.     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-02-09     Completed Date:  2010-04-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8701199     Medline TA:  Hum Reprod     Country:  England    
Other Details:
Languages:  eng     Pagination:  734-41     Citation Subset:  IM    
Affiliation:
Department of Gynecology, Universit? Catholique de Louvain, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, 1200 Brussels, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Arachidonate 5-Lipoxygenase / genetics
Cyclooxygenase 2 / genetics
Eicosanoids / biosynthesis*
Endometriosis / enzymology*
Endometrium / enzymology*
Female
Humans
Hydroxyprostaglandin Dehydrogenases / genetics
Intramolecular Oxidoreductases / genetics
Macrophages, Peritoneal / enzymology
Metabolic Networks and Pathways
Peritoneum / enzymology,  pathology
Phospholipases A2, Secretory / genetics
RNA, Messenger / metabolism
Chemical
Reg. No./Substance:
0/Eicosanoids; 0/RNA, Messenger; EC 1.1.1.-/Hydroxyprostaglandin Dehydrogenases; EC 1.1.1.141/15-hydroxyprostaglandin dehydrogenase; EC 1.13.11.34/Arachidonate 5-Lipoxygenase; EC 1.14.99.1/Cyclooxygenase 2; EC 1.14.99.1/PTGS2 protein, human; EC 3.1.1.4/Phospholipases A2, Secretory; EC 5.3.-/Intramolecular Oxidoreductases; EC 5.3.99.3/prostaglandin-E synthase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Patients' conceptualization of cryopreserved embryos used in their fertility treatment.
Next Document:  The experience of spontaneous pregnancy loss for infertile women who have conceived through assisted...